ClinicalTrials.Veeva

Menu

Impact of High Protein and Low Carbohydrate Smoothie Drinks in Type-2 Diabetes Mellitus

M

Mahidol University

Status

Completed

Conditions

Diabetes Mellitus, Type 2

Treatments

Dietary Supplement: conventional diabetic enteral drinks (Glucerna)
Dietary Supplement: smoothie with low carbohydrate formulas (SMLS)
Dietary Supplement: smoothie with regular formulas (SM)

Study type

Interventional

Funder types

Other

Identifiers

NCT04577274
814/2562 (IRB3)

Details and patient eligibility

About

We compared between a regular high protein or a high protein and low carbohydrate smoothie drinks with conventional diabetic enteral drinks (Glucerna) on glucose homeostasis, insulin and lipid metabolism in type 2 diabetic and obese individuals.

Full description

We aimed to determine the effect of high protein and low carbohydrate smoothie drinks on glucose homeostasis, insulin and lipid metabolism in type 2 diabetic and obese individuals. We compared between a regular high protein or a high protein and low carbohydrate smoothie drinks with conventional diabetic enteral drinks (Glucerna). A crossover design study was done in 60 diabetic participants. Participants consumed 300 kilocalories of each drink at a time with one week wash out period between drinks and glucose response curves at baseline, 30, 60, 90, 120, 180 and 240 minutes were monitored and compared. The products were formulated to supply 1 kilocalorie/milliliter (kcal/ml). Dietary compositions in regular formulas (smoothie, SM) were 30-40% carbohydrate, 20-30% protein and 30-50% fat. While in smoothie with low carbohydrate formulas (SMLS), they were 25-35% carbohydrate, 25-30% protein and 35-55% fat vs. a control formula (Glucerna).

Enrollment

43 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. people with type 2 diabetes mellitus or use blood glucose-lowering drugs more than 3 months
  2. BMI > 25 kg/m^2
  3. HbA1c 6.5 - 8.5
  4. use stable level of blood glucose-lowering drugs and blood lipid-lowering drugs more than 3 months

Exclusion criteria

  1. pregnancy or breastfeeding
  2. people with chronic diseases or tube feeding or dysphagia i.e. pneumonia
  3. people with insulin injection or use GLP-1 analogues drugs or DPP-4 inhibitors drugs
  4. people with history of bariatric surgery, gastroparesis, malabsorption
  5. people with history of diseases that affect blood glucose/lipid control i.e. hyperthyroidism, endocrinology and kidney disorders
  6. use long-term immunosuppressants
  7. cancer patient

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

43 participants in 3 patient groups

smoothie with regular formulas (SM)
Experimental group
Description:
Participants were given 300 kcal smoothie with regular formulas within 3-5 minutes and blood collection after drinking at 30, 60, 90, 120, 180 and 240 minutes.
Treatment:
Dietary Supplement: smoothie with regular formulas (SM)
smoothie with low carbohydrate formulas (SMLS)
Experimental group
Description:
Participants were given 300 kcal smoothie with low carbohydrate formulas within 3-5 minutes and blood collection after drinking at 30, 60, 90, 120, 180 and 240 minutes.
Treatment:
Dietary Supplement: smoothie with low carbohydrate formulas (SMLS)
conventional diabetic enteral drinks (Glucerna)
Active Comparator group
Description:
Participants were given 300 kcal Glucerna within 3-5 minutes and blood collection after drinking at 30, 60, 90, 120, 180 and 240 minutes.
Treatment:
Dietary Supplement: conventional diabetic enteral drinks (Glucerna)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems